Quinidine Pharmacokinetics in Continuous Abulatory Peritoneal Dialysis
Clinical and Experimental Dialysis and Apheresis · 1981
DOI: 10.3109/08860228109076030 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical and Experimental Dialysis and Apheresis, 1981. Verfasst von T W Chin und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Peritoneal Dialysis, Continuous Ambulatory. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
The clearance of quinidine was evaluated in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). The dialysis clearance of quinidine was 0.793 ml/min which represented only 0.61% of the total body clearance (154.21 ml/min) of the drug. The elimination half-life of quinidine was 5.44 hours. Based on our results, dosage adjustment of quinidine does not appear to be necessary for patients undergoing CAPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Chin, T. W., Pancorbo, S., & Comty, C. (1981). Quinidine Pharmacokinetics in Continuous Abulatory Peritoneal Dialysis. Clinical and Experimental Dialysis and Apheresis. https://doi.org/10.3109/08860228109076030
Vancouver
Chin TW, Pancorbo S, Comty C. Quinidine Pharmacokinetics in Continuous Abulatory Peritoneal Dialysis. Clinical and Experimental Dialysis and Apheresis. 1981. doi:10.3109/08860228109076030
BibTeX
@article{Chin1981,
author = {Chin, T W and Pancorbo, S and Comty, C},
title = {Quinidine Pharmacokinetics in Continuous Abulatory Peritoneal Dialysis},
journal = {Clinical and Experimental Dialysis and Apheresis},
year = {1981},
doi = {10.3109/08860228109076030}
}
EUVIMED